We are live on
!
Find out more
SCM
Salem Capital Management Portfolio holdings
AUM
$126M
1-Year Est. Return
8.82%
This Fund
S&P 500
This Quarter
Est. Return
+0.94%
1 Year Est. Return
-8.82%
3 Year Est. Return
+32.26%
5 Year Est. Return
+45.09%
10 Year Est. Return
–
AUM
$210M
AUM Growth
–
Cap. Flow
+$213M
Cap. Flow
% of AUM
101.39%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
73
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$8.79M |
| 2 |
Unilever
UL
|
+$8.01M |
| 3 |
Johnson & Johnson
JNJ
|
+$7.54M |
| 4 |
Honeywell
HON
|
+$7.31M |
| 5 |
Weyerhaeuser
WY
|
+$7.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.57% |
| 2 | Technology | 17.19% |
| 3 | Energy | 15.98% |
| 4 | Industrials | 12.03% |
| 5 | Consumer Staples | 8.94% |
Similar funds
FFC
WC
SP
EVC
HGM
JSMC
RCM
DIV
Salem Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Salem Capital Management, which disclosed 73 positions worth $210M. Its ten largest holdings account for 33% of the portfolio.
Its largest position is CVS Health: 151,794 shares worth $8.68M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Energy.
- Salem Capital Management's largest Q2 2013 buy was CVS Health: 151,794 shares worth $8.68M.
- Salem Capital Management's ten largest holdings make up 33% of its $210M portfolio in Q2 2013.
- Salem Capital Management disclosed 73 positions in Q2 2013, its first 13F filing on record.
Based on Salem Capital Management's 13F filing for Q2 2013, filed 6 Aug 2013.